"V体育平台登录" Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
- PMID: 22297845
- PMCID: PMC3276682
- DOI: "VSports在线直播" 10.1038/nature10809
Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
Abstract
Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of metabolic syndrome and the leading cause of chronic liver disease in the Western world. Twenty per cent of NAFLD individuals develop chronic hepatic inflammation (non-alcoholic steatohepatitis, NASH) associated with cirrhosis, portal hypertension and hepatocellular carcinoma, yet the causes of progression from NAFLD to NASH remain obscure VSports手机版. Here, we show that the NLRP6 and NLRP3 inflammasomes and the effector protein IL-18 negatively regulate NAFLD/NASH progression, as well as multiple aspects of metabolic syndrome via modulation of the gut microbiota. Different mouse models reveal that inflammasome-deficiency-associated changes in the configuration of the gut microbiota are associated with exacerbated hepatic steatosis and inflammation through influx of TLR4 and TLR9 agonists into the portal circulation, leading to enhanced hepatic tumour-necrosis factor (TNF)-α expression that drives NASH progression. Furthermore, co-housing of inflammasome-deficient mice with wild-type mice results in exacerbation of hepatic steatosis and obesity. Thus, altered interactions between the gut microbiota and the host, produced by defective NLRP3 and NLRP6 inflammasome sensing, may govern the rate of progression of multiple metabolic syndrome-associated abnormalities, highlighting the central role of the microbiota in the pathogenesis of heretofore seemingly unrelated systemic auto-inflammatory and metabolic disorders. .
Conflict of interest statement
The authors report no conflict of interest.
Figures






Comment in
-
Gut microbiota influences liver disease.Nat Rev Immunol. 2012 Feb 17;12(3):153. doi: 10.1038/nri3177. Nat Rev Immunol. 2012. PMID: 22343570 No abstract available.
-
"V体育ios版" Microbiota: Dysbiosis driven by inflammasome deficiency exacerbates hepatic steatosis and governs rate of NAFLD progression.Nat Rev Gastroenterol Hepatol. 2012 Feb 21;9(3):123. doi: 10.1038/nrgastro.2012.21. Nat Rev Gastroenterol Hepatol. 2012. PMID: 22349167 No abstract available.
-
V体育ios版 - Is predisposition to NAFLD and obesity communicable?Cell Metab. 2012 Apr 4;15(4):419-20. doi: 10.1016/j.cmet.2012.03.013. Cell Metab. 2012. PMID: 22482724
-
Transmissible fatty liver disease.Am J Transplant. 2012 May;12(5):1071. doi: 10.1111/j.1600-6143.2012.04095.x. Am J Transplant. 2012. PMID: 22537259 No abstract available.
-
"VSports app下载" Liver repercussions of defective gut surveillance.Hepatology. 2012 Sep;56(3):1174-7. doi: 10.1002/hep.25944. Hepatology. 2012. PMID: 22930647 No abstract available.
References
-
- Sheth SG, Gordon FD, Chopra S. Nonalcoholic steatohepatitis. Ann Intern Med. 1997;126:137–145. - PubMed
-
- Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc. 1980;55:434–438. - PubMed
-
- Marchesini G, et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology. 2003;37:917–923. - PubMed
-
- Caldwell SH, et al. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology. 1999;29:664–669. - PubMed
-
- Shimada M, et al. Hepatocellular carcinoma in patients with non-alcoholic steatohepatitis. J Hepatol. 2002;37:154–160. - PubMed
"V体育2025版" Publication types
- V体育官网入口 - Actions
- Actions (V体育官网入口)
"VSports在线直播" MeSH terms
- "V体育官网" Actions
- V体育官网入口 - Actions
- "VSports注册入口" Actions
- VSports最新版本 - Actions
- "VSports注册入口" Actions
- "V体育官网" Actions
- VSports - Actions
- VSports手机版 - Actions
- "VSports app下载" Actions
- VSports注册入口 - Actions
- Actions (V体育安卓版)
- V体育ios版 - Actions
- VSports注册入口 - Actions
- "VSports app下载" Actions
VSports app下载 - Substances
- V体育官网入口 - Actions
- "V体育官网" Actions
- "VSports手机版" Actions
- Actions (VSports注册入口)
- Actions (V体育安卓版)
- VSports注册入口 - Actions
- Actions (V体育安卓版)
- VSports在线直播 - Actions
- "V体育官网入口" Actions
- V体育平台登录 - Actions
- "VSports" Actions
- "V体育安卓版" Actions
- "V体育官网" Actions
Grants and funding
- R24 DK-085638/DK/NIDDK NIH HHS/United States
- HHMI/Howard Hughes Medical Institute/United States
- U24 DK059635/DK/NIDDK NIH HHS/United States (V体育官网入口)
- "VSports手机版" P30 DK-45735/DK/NIDDK NIH HHS/United States
- U24 DK-059635/DK/NIDDK NIH HHS/United States
- T32 HL007974/HL/NHLBI NIH HHS/United States
- R01 DK-40936/DK/NIDDK NIH HHS/United States
- VSports注册入口 - R01 DK076674/DK/NIDDK NIH HHS/United States
- R01 DK040936/DK/NIDDK NIH HHS/United States
- K08A1085038/PHS HHS/United States
- R01DK076674-01/DK/NIDDK NIH HHS/United States
- R24 DK085638/DK/NIDDK NIH HHS/United States
- P30 DK045735/DK/NIDDK NIH HHS/United States
- "VSports" T32HL007974/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
VSports app下载 - Medical
VSports注册入口 - Molecular Biology Databases
Miscellaneous